Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
24 April 2024 - 1:00PM
The Professional Pickleball Association (PPA) Tour and Treace
Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology
company driving a fundamental shift in the surgical treatment of
bunions and related midfoot deformities through its flagship
Lapiplasty® and Adductoplasty® Procedures, today announced that
Treace Medical has been named the first Medical Device Partner and
Official Foot and Ankle Solution Partner for the PPA Tour.
Treace was the first medical device company to
become a PPA sponsor at last year’s National Championships.
Beginning with the Fanatics Sportsbook North Carolina Cup
presented by CIBC earlier this month, Treace Medical’s partnership
includes dedicated space and fan activations at six PPA Tour events
with thousands of fans and players at stops across the country.
Additionally, official player challenges of calls during a match
will now be known as the “Bunion Challenge.” The partnership will
also include signage, clinics and pro experiences.
“We’re proud and excited to welcome Treace
Medical to the PPA Tour,” said PPA Tour Founder and CEO Connor
Pardoe. “Footwork is a key component of playing pickleball at the
highest level, and to be aligned with the experts and leaders in
the field of bunion and related midfoot deformities will help
players of all skill levels to perform at their best.”
As the Official Foot and Ankle Solution Partner
for the PPA Tour, Treace is uniquely positioned to drive greater
awareness of the challenges posed by bunions, which affect over 67
million Americans,1 and educate patients on its pioneering
Lapiplasty® procedure, the #1 most commonly used 3D bunion
correction procedure by U.S. surgeons.2
“As the fastest growing company in the foot and
ankle market,3 we are thrilled to partner with the PPA Tour to
support the fastest growing sport in America,” said John T. Treace,
CEO and Founder of Treace. “Since our first surgical cases in 2015,
over 100,000 patients have chosen the Lapiplasty® procedure to
address painful, lifestyle-limiting bunions with the goal to get
back on their feet in sneakers at 6-8 weeks.4,5 We look forward to
reaching even more people through our partnership with the PPA Tour
and raising awareness of the impact that effective bunion treatment
can have on the quality of life for patients.”
The Carvana PPA Tour is the premier pickleball
tour, showcasing the world’s best players week in and week out all
across the country. Top players like World No.1s Ben Johns and Anna
Leigh Waters and tennis champs-turned-pickleball-pros Jack Sock and
Genie Bouchard will be fighting for gold in singles, doubles and
mixed doubles at this year’s prestigious events on the PPA Tour
calendar.
Treace Medical will make their next stop on the
PPA Tour at the Veolia Sacramento Open, June 5-9. For tickets and
to register to compete, visit ppatour.com.
About Carvana PPA TourFounded
in 2019, the Carvana PPA Tour is where pickleball’s top athletes go
head-to-head to determine the best male and female players in the
world. The Carvana PPA Tour organizes and conducts tournaments at
world-class facilities across the country, establishes player
rankings, and showcases the world’s best pickleball week in and
week out. Inviting amateur players to also compete and “play where
the pros play,” the Carvana PPA Tour offers divisions for every age
group and skill level. Characterized by a uniquely festive and fun
atmosphere, Carvana PPA Tour events deliver unparalleled
experiences for fans on-site, including pro player meet-and-greets,
clinics, food, beverages, live entertainment, giveaways, games,
shopping, and VIP upgrades. For more information, go to
www.ppatour.com, and follow us on social: Twitter, Instagram,
YouTube, Facebook, LinkedIn.
About Treace Medical
ConceptsTreace Medical Concepts, Inc. is a medical
technology company with the goal of advancing the standard of care
for the surgical management of bunion and related midfoot
deformities. Bunions are complex 3-dimensional deformities that
originate from an unstable joint in the middle of the foot and
affect approximately 67 million Americans, of which Treace
estimates 1.1 million are annual surgical candidates. Treace has
pioneered and patented the Lapiplasty® 3D Bunion
Correction® System – a combination of instruments, implants,
and surgical methods designed to surgically correct all three
planes of the bunion deformity and secure the unstable joint,
addressing the root cause of the bunion and helping patients get
back to their active lifestyles. To further support the needs of
bunion patients, Treace has introduced its
Adductoplasty® Midfoot Correction System, designed for
reproducible surgical correction of the midfoot as well as its
Hammertoe PEEK Fixation System designed to address hammertoe, claw
toe and mallet toe deformities. The Company continues to expand its
footprint in the foot and ankle market with the introduction of its
SpeedPlate™ Rapid Compression Implants, an innovative fixation
platform with broad versatility across Lapiplasty® and
Adductoplasty® procedures, as well as other common bone fusion
procedures of the foot. For more information, please visit
www.treace.com and connect with us on LinkedIn, Twitter, Facebook
and Instagram.
1 Nix S, et al. J Foot Ankle Res. 2010;3:21.2 AOFAS Member
Survey August 2023.3 TMC estimate based on other publicly-traded
peers participating in the foot and ankle market.4 TMC Data on
File.5 Individual results and recovery times may vary. Ray J, et
al. Foot Ankle Int. 2019 Aug;40(8):955-960.
Media Contact: Jeff Watson, VP of
Communications, PPA Tour j.watson@ppatour.com, 817-944-2298
Treace Medical Concepts,
Inc.Julie Dewey, Chief Communications & IR Officer,
jddewey@treace.com, 209-613-6945
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/7feb977a-0832-4004-88db-1d47a24f9cec.
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024